North America Over the Counter Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers OTC Drugs List in North America and the market is segmented by Product Type, By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other Distribution Channels) and Geography. The market provides the value (in USD million) for the above-mentioned segments.

North America Over the Counter Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Over the Counter Drugs Market Size

View Global Report
North America OTC Market-1
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 2.70 %

Major Players

North America Over the Counter Drugs Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Over the Counter Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Over the Counter Drugs Market Analysis

The North America Over the Counter Drugs Market is expected to register a CAGR of 2.7% during the forecast period.

The OTC drugs market is innovation-driven and relies on the advent of innovative drugs for different disease complexities and vary in their degree of intensity, and efficacy. The product innovations in OTC drugs have built confidence among the consumers and have resulted in the increased demand for OTC drugs. Although the market share is high in the North American region, the USA's share is less when compared to the other countries on a global forefront. This can be due to the strict regulatory measures taken by the US government in the labelling of drugs as OTC. But in recent times, there has been a change in opinion regarding the OTC market. The potential benefits have been identified and as a result, OTC drugs have been made more accessible.

According to the Consumer Healthcare Products Association, 2019, it was estimated that about 93% of the Americans prefer to treat their minor ailments with OTC medicines before seeking professional care. For the treatment of musculoskeletal injuries and disorders, many patients in the United States generally use nonprescription topical analgesics. Counterirritants are approved by the FDA for the topical treatment of minor pains and muscle and joint aches and are often used for the treatment of acute musculoskeletal injuries, such as simple backache, arthritis pain, strains, bruises, and sprains. Thus, owing to above factors the market is expected to show growth over the forecast period.

North America Over the Counter Drugs Industry Overview

North America over the counter drugs market is fragmented competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. Companies, like Johnson and Johnson, Novartis AG, Bayer AG, Sanofi, and Pfizer, hold significant market shares in North America over the counter drugs market.

North America Over the Counter Drugs Market Leaders

  1. Sanofi

  2. Johnson and Johnson

  3. Novartis AG

  4. Pfizer Inc

  5. Bayer AG

  6. *Disclaimer: Major Players sorted in no particular order
NA OTC landscspe.png
Need More Details on Market Players and Competiters?
Download PDF

North America Over the Counter Drugs Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Product Innovations
    • 4.2.2 Inclination of Pharmaceutical Companies Toward OTC Drugs from RX Drugs
  • 4.3 Market Restraints
    • 4.3.1 Probability of Substance Abuse
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Cough, Cold, and Flu Products
    • 5.1.2 Analgesics
    • 5.1.3 Dermatology Products
    • 5.1.4 Gastrointestinal Products
    • 5.1.5 Vitamins, Mineral, and Supplements (VMS)
    • 5.1.6 Weight-loss/Dietary Products
    • 5.1.7 Ophthalmic Products
    • 5.1.8 Sleeping Aids
    • 5.1.9 Other Product Types
  • 5.2 By Distribution Channel
    • 5.2.1 Hospital Pharmacies
    • 5.2.2 Retail Pharmacies
    • 5.2.3 Online Pharmacy
    • 5.2.4 Other Distribution Channels
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson and Johnson
    • 6.1.2 Novartis AG
    • 6.1.3 Bayer AG
    • 6.1.4 Sanofi
    • 6.1.5 Pfizer Inc
    • 6.1.6 GlaxoSmithKline Plc
    • 6.1.7 Perrigo Company Plc
    • 6.1.8 Takeda Pharmaceutical Company Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Over the Counter Drugs Industry Segmentation

As per the scope of this report, over the counter drugs are referred to as non-prescription drugs. These medicines can be bought by an individual without the doctor's prescription and are safe for consumption without the doctor's consent. North America over the counter drugs market is segmented by product type, distribution channel, and geography.

By Product Type Cough, Cold, and Flu Products
Analgesics
Dermatology Products
Gastrointestinal Products
Vitamins, Mineral, and Supplements (VMS)
Weight-loss/Dietary Products
Ophthalmic Products
Sleeping Aids
Other Product Types
By Distribution Channel Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Other Distribution Channels
Geography North America United States
Canada
Mexico
Need A Different Region or Segment?
Customize Now

North America Over the Counter Drugs Market Research FAQs

What is the current North America Over the Counter Drugs Market size?

The North America Over the Counter Drugs Market is projected to register a CAGR of 2.7% during the forecast period (2025-2030)

Who are the key players in North America Over the Counter Drugs Market?

Sanofi, Johnson and Johnson, Novartis AG, Pfizer Inc and Bayer AG are the major companies operating in the North America Over the Counter Drugs Market.

What years does this North America Over the Counter Drugs Market cover?

The report covers the North America Over the Counter Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Over the Counter Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Over The Counter Industry Report

Statistics for the 2025 North America Over the Counter Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Over the Counter Drugs analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.